Microlife
SCHWEIZ
Deutsch
Europe
Asia Middle East and North Africa
USA, Latin America
Menu
Header Validations WatchBP Flow

Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol

Home > WatchBP Produkte > Validations and clinical studies > Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol, Ragazzo, 2010

Fabio Ragazzo, Francesca Saladini and Paolo Palatini, 2010

Abstract

To determine the accuracy of the Microlife WatchBP O3 blood pressure measuring device tested according to the requirements of the International Protocol of the European Society of Hypertension. The WatchBP O3 is designed to provide clinic, ambulatory, and self blood pressure (BP) measurements. Device evaluation was performed in 33 participants with a mean ± standard deviation age of  56.1± 20.7 years (range 30–95 years). Their systolic BP (SBP) was 144.7± 24.1mmHg (range 90–180 mmHg), diastolic BP (DBP) was 86.8 ± 18.3mmHg (range 50–120 mmHg), and arm circumference was 28.1 ± 2.9cm (range 22.0–34.0 cm). Blood pressure measurements were performed in the sitting position. The WatchBP O3 passed all three phases of the European Society of Hypertension protocol for SBP and DBP. Mean blood pressure differences for the WatchBP O3 (device observer) were – 1.7 ± 6.9mmHg for SBP and – 1.1 ± 4.3mmHg for DBP. In conclusion, these results indicate that the Microlife WatchBP O3 monitor can be recommended for clinical use in the adult population.

Click here to download the abstract in pdf format

 

Copyright © 2025 - Microlife Corporation. All rights reserved.